Our history

1967 - 2007

Specialty clinical pathology laboratory

1967

Creation of Laboratoire Cerba  (Centre d’études et de recherches en biologie appliquée): a reference lab that performs clinical pathology on behalf of other public and private laboratories.

1990

Creation of Cerba’s anatomocytopathology department

1992

Creation of Cerba’s  human genetics department

1998

Merge with the infectiology expert  Institut Pasteur's specialized clinical pathology centre

 

Pasteur-Cerba began the first  european specialized  clinical pathology laboratory

1999

COFRAC Accreditation EN CEI ISO 17025: Cerba, first laboratory accredited in France.

2001

Creation of Cerba’s vet health department

2002

Development of Cerba’s activities  in Africa and Middle East

2007

New activity and new geographic position: routine activity and clinical trials in Belgium

2007

Acquisition of Barc Group, clinical pathology leader in Belgium and clinical trials’ global player.

Acquisition of CRI and LBS laboratories in Belgium

Cerba becomes Cerba European Lab

2009 - 2014

New activity and new geographic positions: routine activity in France and Luxembourg

2009

Acquisition of Laboratoire Biolille

2010

Acquisition of Biotop and CBCV

2011

Acquisition of Bioréunion, Ketterthill, BioPyrénéesLab and Medic Lab laboratories.

2012

Acquisition of Biobaie and Biopole 80

2013

Acquisition of CBM 76

 

Cerba is the first specialized clinical pathology laboratory in France to perform screening tests for trisomy 13, 18 and 21 by free circulating DNA available to the medical community.

 

Launch of Biopredix, first preventive medicine check-ups to preserve health capital.

 

Creation of Cerba Specimen Services, branch dedicated to IVD industries.

2014

Acquisition of CMP, anatomocytopatholgy laboratory in Brussels.

2015 - 2016

New activity: veterinary clinical pathology and genetics

Development of Cerballiance network in France

2015

Acquisition of Novescia, Bioponant, laboratoires Goelab, Vigibio, Cerdibio et Labo 17

 

Cerba European Lab becomes 

Cerba HealthCare

 

Creation of Institut Cerba endowment fund for socially inclusive and responsible clinical pathology

 

Creation of Cerba Vet, veterinary clinical pathology laboratory.

2016

Launch of Cerba HealthCare University, a pioneering initiative in the clinical pathology market.

 

Acquisition of Antagene, DNA tests for parentage certification and disease prevention in dogs and cats.

 

Creation of Cerballiance network bringing together all the routine laboratories in France

 

Cerba is the first private laboratory to perform exome sequencing and thus committed to the diagnosis of rare constitutional genetic diseases


 

2017 - 2023

New geographic positions: routine clinical pathology in Africa and Italy

New activity: medical imaging in Italy

Development of routine clinical pathologyin France and veterinary clinical pathology in France and Switzerland.

Development of clinical trials activities in Netherlands, Canada and Asia.

2017

Acquisition of the Italian laboratories Deltamedica et Fleming Research

2018

Acquisition of BIO 7

 

Cerba Specimen Services becomes Cerba Xpert

 

Acquisition of  Histalim to strengthen Barc’s expertise in anatomocytopathology

2019

Launch of Cerba Sport, a complete range of tests to optimize sports performance

 

Creation of Cerba Lancet Africa: Group’s establishment in Africa  to develop a network of laboratories in partnership with Lancet Laboratories, South Africa’s leader in clinical pathology

 

Lauch of Innov Lab, a platform that enables every employee to post ideas, participate in innovation challenges and get informed about ongoing initiatives and new projetcs throughout the Group

2020

Barc, Histalim  and Cerba Xpert become Cerba Research, branch dedicated to clinical pathology for clinical trials serving the biotechnology, pharmaceutical and in vitro diagnostics industries.

 

Creation of Cerba Path, anatomocytopathology experts’ network.

.

2021

Acquisition of the Italian laboratories Lifebrain. Cerba HealthCare becomes the market leader in medical diagnosis in Italy.

 

Creation of CerbACT Asia (strategic joint-venture between Cerba Research and ACT Genomics) : a purpose-built lab facility in Taiwan covering the Asia Pacific region.

 

Acquisition of Labexa, a leading clinical pathology group in the Nouvelle Aquitaine region.

 

Acquisition of Viroclinics-DDL, a fast-growing global virology and immunology contract research organization (CRO).

2022

Acquisition of Yourlab, a clinical pathology group based in western France.

 

Cerba Lancet Africa signs strategic partnership with International Clinical Laboratories in Ethiopia

 

Publication of the first CSR report

2023

Animal Diagnostic, IHP VETO, LAPVSO, Orbio et Scanelis join the Cerba Vet centre of excellence 

 

Acquisition of CIRION BioPharma Research (canadian contract research laboratory) to expand the Group’s bioanalytical capabilities and shorten time-to-deploy complex clinical trials

 

Creation of Cerba HealthCare Saudi Arabia (strategic joint venture between Cerba HealthCare and Nexus Gulf Healthcare) to contribute to the upcoming transformation of healthcare system in Saudi Arabia